How is Kaposi sarcoma (KS) prevented?

Updated: Mar 30, 2020
  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Dirk M Elston, MD  more...
  • Print

Reducing the HHV-8 infection rate prevents Kaposi sarcoma development.

Suggestions have been made that some antiherpetic agents, particularly foscarnet, may lower the HHV-8 infection rate.

Screening transplant recipients for HHV-8 infection may be beneficial. [71, 72, 73, 74, 75]

Use of the highly active anti-HIV therapy HAART appears to reduce the risk of developing new Kaposi sarcoma significantly.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!